Eurofins Acquires Genetic Testing Service JSC (Gentis) in Vietnam

Eurofins (via Eurofins Clinical Testing Lux) Acquires Genetic Testing Service JSC (Gentis) in Vietnam

February 9, 2022

Healthcare Services

Eurofins Scientific, through its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a market leader in specialised genetic testing in Vietnam. The deal expands Eurofins' footprint in Southeast Asia and strengthens its clinical genetics and advanced molecular diagnostics capabilities in the region.

Eurofins Acquires DNA Diagnostics Center from GHO Capital

June 28, 2021

Healthcare Services

Eurofins, the publicly traded global laboratory testing group, has agreed to acquire DNA Diagnostics Center (DDC), a consumer-focused DNA testing company based in Fairfield, Ohio, from GHO Capital. DDC, which has approximately 240 employees and a broad portfolio of at‑home and lab-based DNA tests, will join Eurofins to expand its consumer genetics and health & wellness testing capabilities and global reach.

Eurofins Scientific Acquires Infinity Laboratories

September 16, 2024

Healthcare Services

Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.

Discovery Life Sciences Acquires Gentest Business from Corning Incorporated

April 5, 2022

Biotechnology

Discovery Life Sciences has acquired the Gentest business unit from Corning Incorporated to expand its in vitro ADME and toxicology reagent and services offering. The deal complements Discovery’s recent acquisition of In Vitro ADMET Laboratories (IVAL) and strengthens its hepatocyte, microsome and ADME-related product and contracted research capabilities for pharmaceutical and life sciences customers.

Eurofins Scientific Acquires bioskin GmbH

August 4, 2021

Healthcare Services

Eurofins Scientific has completed the acquisition of bioskin GmbH, a Hamburg-based dermatology-focused CRO that provides clinical trials for drugs, medical devices, food supplements and advanced cosmetics. The deal expands Eurofins' clinical study management and dermatology capabilities in Germany and strengthens its Cosmetics & Personal Care testing offering.

Solvias Acquires Cergentis

July 13, 2022

Biotechnology

Swiss analytical contract research and manufacturing company Solvias acquired Utrecht-based genomics services provider Cergentis on July 12, 2022. The deal adds Cergentis' proprietary Targeted Locus Amplification (TLA) genomic analysis capabilities to Solvias' biologics and cell & gene therapy testing platform to expand its advanced-therapy testing services globally.